Determinants of plasma PTH and their implication for defining a reference interval

Clinical Endocrinology

Volumn 74, Issue 1, 2011, Pages 37-43

  Rejnmark, Lars ^a   Vestergaard, Peter ^a   Heickendorff, Lene ^a   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; CREATININE; PARATHYROID HORMONE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SEASONAL VARIATION; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; PARATHYROID HORMONE; VITAMIN D; YOUNG ADULT;

EID: 78650324184     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03894.x     Document Type: Article

References (32)

1. Saleh, F., Jorde, R., Svartberg, J., et al. (2006) The relationship between blood pressure and serum parathyroid hormone with special reference to urinary calcium excretion: the Tromso study. Journal of Endocrinological Investigation, 29, 214-220.
2. Sato, Y., Kaji, M., Metoki, N., et al. (2003) Does compensatory hyperparathyroidism predispose to ischemic stroke? Neurology, 60, 626-629.
3. Sambrook, P.N., Chen, J.S., March, L.M., et al. (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxyvitamin D status, bone mass, and renal function in the frail and very old: a cohort study. Journal of Clinical Endocrinology and Metabolism, 89, 5477-5481.
4. Bjorkman, M.P., Sorva, A.J., &, Tilvis, R.S., (2008) Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. European Journal of Endocrinology, 158, 749-753.
5. Carlstedt, F., Lind, L., Wide, L., et al. (1997) Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department [see comments]. European Journal of Clinical Investigation, 27, 977-981.
6. Chen, J.S., Sambrook, P.N., March, L., et al. (2008) Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clinical Endocrinology, 68, 290-298.
7. Hagstrom, E., Hellman, P., Larsson, T.E., et al. (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation, 119, 2765-2771.
8. Aloia, J.F., Feuerman, M., &, Yeh, J.K., (2006) Reference range for serum parathyroid hormone. Endocrine practice, 12, 137-144.
9. Vieth, R., Ladak, Y., &, Walfish, P.G., (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism, 88, 185-191.
10. Glendenning, P., &, Vasikaran, S.D., (2002) Vitamin D status and redefining serum PTH reference range in the elderly. Journal of Clinical Endocrinology and Metabolism, 87, 946-947.
11. Souberbielle, J.C., Cormier, C., Kindermans, C., et al. (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism, 86, 3086-3090.
12. Eastell, R., Arnold, A., Brandi, M.L., et al. (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 340-350.
13. Rejnmark, L., Tietze, A., Vestergaard, P., et al. (2009) Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiology, Biomarkers and Prevention, 18, 2655-2660.
14. Maunsell, Z., Wright, D.J., &, Rainbow, S.J., (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clinical Chemistry, 51, 1683-1690.
15. Hojskov, C.S., Heickendorff, L., &, Moller, H.J., (2010) High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clinica Chimica Acta, 411, 114-116.
16. Gault, M.H., Longerich, L.L., Harnett, J.D., et al. (1992) Predicting glomerular function from adjusted serum creatinine. Nephron, 62, 249-256.
17. CLSI Document C28-A3 (2008) Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline, 3rd edn. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
18. Blind, E., Schmidt-Gayk, H., Armbruster, F.P., et al. (1987) Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clinical Chemistry, 33, 1376-1381.
19. Arky, R.A., (2005) "Doctor, Is My Sugar Normal?". New England Journal of Medicine, 353, 1511-1513.
20. Lahti, A., (2004) Partitioning biochemical reference data into subgroups: comparison of existing methods. Clinical Chemistry and Laboratory Medicine, 42, 725-733. (Pubitemid 39137220)
21. Autier, P., &, Gandini, S., (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine, 167, 1730-1737.
22. Fisher, A., Goh, S., Srikusalanukul, W., et al. (2009) Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcified Tissue International, 85, 301-309.
23. Ooms, M.E., Roos, J.C., Bezemer, P.D., et al. (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. Journal of Clinical Endocrinology and Metabolism, 80, 1052-1058.
24. Chapuy, M.C., Pamphile, R., Paris, E., et al. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis International, 13, 257-264.
25. Malabanan, A., Veronikis, I.E., &, Holick, M.F., (1998) Redefining vitamin D insufficiency. Lancet, 351, 805-806.
26. Steingrimsdottir, L., Gunnarsson, O., Indridason, O.S., et al. (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA, 294, 2336-2341.
27. Chapuy, M.C., Preziosi, P., Maamer, M., et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International, 7, 439-443.
28. Kuchuk, N.O., van Schoor, N.M., Pluijm, S.M., et al. (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. Journal of Bone and Mineral Research, 24, 693-701.
29. Need, A.G., O'Loughlin, P.D., Morris, H.A., et al. (2004) The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. Journal of Clinical Endocrinology and Metabolism, 89, 1646-1649.
30. Lips, P., Chapuy, M.-C., Dawson-Huges, B., et al. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis International, 9, 394-397.
31. Roth, H.J., Schmidt-Gayk, H., Weber, H., et al. (2008) Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Annals of Clinical Biochemistry, 45, 153-159.
32. Rejnmark, L., Lauridsen, A.L., Vestergaard, P., et al. (2002) Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. European Journal of Endocrinology, 146, 635-642.